TYK Medicines, Inc. was established in 2018, positioned as an international innovative biotechnology company, and “In China, For Global”. The company focuses on the research and development of new anti-cancer drugs. Our mission is to gather global drug development expertise and “Together we search for the cure”.
History and experienced team TYK Medicines Inc., registered in Zhejiang Province and operates in Shanghai and Zhejiang. Currently TYK has a highly experienced 30+ full-time employee team with 6 returnees from US. The team has accumulated experiences of discovery and development over 10+ drug candidates in major pharmaceutical companies, from initiating a discovery program to eventually bringing a drug to the market. In less than two years, two IND filings have been successfully submitted and approved by NMPA, and currently in phase 1 clinical trials. In addition, multiple in-house discovery programs are ongoing and some reaching to PCC stage. Headquarter Xuhui District, Shanghai R&D Center Life Science Park, Changxing Economic Development Zone, Zhejiang Province, a total of 30,000 square meters with fully functionalized biology and chemistry laboratories; equipped with state-of-the-art 400MHz NMR, HPLC, GC/MS, LC/MS, quadrupole MS, high-throughput multi-protein detector, multi-label microplate detector, high-throughput screening system, DSC, TGA, cell culture, etc.